§ 13F · FUND PROFILE

GSK plc.

AUM · $602M (13F)Positions · 13Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 13, 2026
#TickerNameShares$ value% portΔ Q2
1CRSPCRISPR THERAPEUTICS AG3.22M$176M29.2%±0%
2WVEWAVE LIFE SCIENCES LTD18.25M$106M17.6%±0%
3VIRVIR BIOTECHNOLOGY INC8.55M$87M14.5%±0%
4BNTXBIONTECH SE890K$83M13.7%±0%
5IDYAIDEAYA BIOSCIENCES INC1.33M$50M8.3%±0%
6CYTKCYTOKINETICS INC340K$29M4.8%±0%
7LYELLYELL IMMUNOPHARMA INC1.51M$21M3.5%±0%
8SPROSPERO THERAPEUTICS INC9.19M$20M3.4%±0%
9NKTXNKARTA INC3.15M$9M1.5%±0%
10FULCFULCRUM THERAPEUTICS INC1.79M$7M1.1%±0%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE GSK SIGNAL

AC read

GSK plc is a Other fund managing $602 million in assets. The fund runs a focused portfolio of just 13 positions.

Read the full dossier →